Coherus Oncology (CHRS) Net Margin Growth (5y) (2019 - 2026)
Coherus Oncology (CHRS) Net Margin Growth (5y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Coherus Oncology | 221.39 Mn | 116.08 Mn | 10.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 12,300.00 |
| Mar 31, 2026 | 19,698.00 |
| Dec 31, 2025 | 5,949.00 |
| Sep 30, 2025 | 5,203.00 |
| Jun 30, 2025 | 329,536.00 |
| Mar 31, 2025 | -15,130.00 |
| Dec 31, 2024 | -9,123.00 |
| Sep 30, 2024 | 56,453.00 |
| Jun 30, 2024 | 37,900.00 |
| Mar 31, 2024 | 745,908.00 |
| Jun 30, 2022 | 473,363.00 |
| Mar 31, 2022 | 5.15 Mn |
| Dec 31, 2021 | 942,255.00 |
| Sep 30, 2021 | -9,718.00 |
| Jun 30, 2021 | 42,857.00 |
| Mar 31, 2021 | 31,918.00 |
| Dec 31, 2020 | 52,073.00 |
| Sep 30, 2020 | 101,977.00 |
| Jun 30, 2020 | 90,383.00 |
| Mar 31, 2020 | 66,311.00 |